Patents by Inventor Sharlene R. Lim

Sharlene R. Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LPA-ASSOCIATED PROTEIN AND RNA EXPRESSION
    Publication number: 20170314074
    Abstract: Provided herein are, inter alia, methods and biomarkers to determine if a patient has or is at risk for developing an LPA-associated disease, to indicate the progressiveness of the disease, and/or to facilitate evaluation of responsiveness to therapy. Compositions and kits including the biomarker proteins and biomarker RNAs provided herein are further provided.
    Type: Application
    Filed: November 15, 2016
    Publication date: November 2, 2017
    Inventors: Karl Kossen, Sharlene R. Lim, Scott D. Seiwert, Donald Ruhrmund
  • Proteomic IPF markers
    Patent number: 9726677
    Abstract: Provided herein are novel biomarkers for the identification, prediction or monitoring of fibrotic pulmonary diseases (e.g. idiopathic pulmonary fibrosis (IPF)). The biomarkers provided herein may further be used for therapeutic treatment of IPF.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 8, 2017
    Assignee: INTERMUNE, INC.
    Inventors: Karl Kossen, Xiaoli Qin, Sharlene R. Lim, Scott S. Seiwert, Donald Ruhrmund
  • PROTEOMIC IPF MARKERS
    Publication number: 20140286929
    Abstract: Provided herein are novel biomarkers for the identification, prediction or monitoring of fibrotic pulmonary diseases (e.g. idiopathic pulmonary fibrosis (IPF)). The biomarkers provided herein may further be used for therapeutic treatment of IPF.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicant: Intermune, Inc.
    Inventors: Karl Kossen, Xiaoli Qin, Sharlene R. Lim, Scott S. Seiwert, Donald Ruhrmund